Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (101-110 of 240) with videos related to

Pageof 24
Sort By:
Molecular and Cellular Biology|June 1, 1994
A novel basic helix-loop-helix protein is expressed in muscle attachment sites of the Drosophila epidermisP Armand, A C Knapp, A J Hirsch, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|December 8, 1979
[Primary intestinal lymphangiectasis or Waldmann's disease (author's transl)]A Ben Bouali, P Armand, J P Barthe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Rationale for the dosage and schedule of CPT-11 (irinotecan) selected for phase II studies, as determined by European phase I studiesJ P Armand, Y M Extra, G Catimel, et al.
Annales De Gastroenterologie Et D'Hepatologie|March 1, 1984
[Spontaneous intramural hematoma of the esophagus. Apropos of a case]P Boisserie, P Armand, J Boyer, et al.
Journal De Radiologie|August 1, 1995
[Diagnosis of extrapontine myelinolysis preceding central pontine myelinolysis]J P Armand, V Dousset, S Winnock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trialsL P Rivory, M C Haaz, P Canal, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1987
Oxidative biotransformation of the antitumour agent elliptinium acetate: Structural characterization of its human and rat urinary metabolitesB Monsarrat, M Maftouh, G Meunier, et al.
Head & Neck|January 1, 1997
Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma typeA Fandi, A Taamma, N Azli, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|June 22, 2011
A high-temperature Raman scattering study of the phase transitions in GaPO(4) and in the AlPO(4)-GaPO(4) systemE Angot, R Le Parc, C Levelut, et al.
Investigational New Drugs|January 1, 1995
A clinical screening cooperative group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancerM Degardin, J P Armand, B Chevallier, et al.
Pageof 24

Showing results (101-110 of 240) with videos related to

Sort By:
Pageof 24
Molecular and Cellular Biology|June 1, 1994
A novel basic helix-loop-helix protein is expressed in muscle attachment sites of the Drosophila epidermisP Armand, A C Knapp, A J Hirsch, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|December 8, 1979
[Primary intestinal lymphangiectasis or Waldmann's disease (author's transl)]A Ben Bouali, P Armand, J P Barthe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Rationale for the dosage and schedule of CPT-11 (irinotecan) selected for phase II studies, as determined by European phase I studiesJ P Armand, Y M Extra, G Catimel, et al.
Annales De Gastroenterologie Et D'Hepatologie|March 1, 1984
[Spontaneous intramural hematoma of the esophagus. Apropos of a case]P Boisserie, P Armand, J Boyer, et al.
Journal De Radiologie|August 1, 1995
[Diagnosis of extrapontine myelinolysis preceding central pontine myelinolysis]J P Armand, V Dousset, S Winnock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trialsL P Rivory, M C Haaz, P Canal, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1987
Oxidative biotransformation of the antitumour agent elliptinium acetate: Structural characterization of its human and rat urinary metabolitesB Monsarrat, M Maftouh, G Meunier, et al.
Head & Neck|January 1, 1997
Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma typeA Fandi, A Taamma, N Azli, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|June 22, 2011
A high-temperature Raman scattering study of the phase transitions in GaPO(4) and in the AlPO(4)-GaPO(4) systemE Angot, R Le Parc, C Levelut, et al.
Investigational New Drugs|January 1, 1995
A clinical screening cooperative group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancerM Degardin, J P Armand, B Chevallier, et al.
Pageof 24